Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

• Main Authors: Norma A. Téllez-Navarrete (Author), Lucero A. Ramon-Luing (Author), Marcela Muñoz-Torrico (Author), Mario Preciado-García (Author), Karen Medina-Quero (Author), Rogelio Hernandez-Pando (Author), Leslie Chavez-Galan (Author)
• Format: Book
• Published: BMC, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Tuberculosis (TB) is an infectious disease. During TB, regulatory T cells (Treg) are related to poor prognosis. However, information about conventional and unconventional Treg (cTreg and uTreg, respectively) is limited. The tumour necrosis factor (TNF) and its receptors (TNFR1 an...